- Nurix Therapeutics Chief Legal Officer Christine Ring sold 8,148 shares on April 2, 2026.
- Sale price was about USD 15.24 per share.
- Directly held stake fell to 26,453 shares following transaction.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nurix Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001817199-26-000012), on April 02, 2026, and is solely responsible for the information contained therein.
Comments